A glass composition includes: Si.sub.2O, greater than 15 mol % to less than or equal to 32 mol % Al.sub.2O.sub.3, B.sub.2O.sub.3, K.sub.2O, MgO, Na.sub.2O, and Li.sub.2O. The glass composition may have a fracture toughness of greater than or equal 0.75 MPa√m and a Young's modulus of greater than or equal to 80 GPa to less than or equal to 120 GPa. The glass composition is chemically strengthenable. The glass composition may be used in a glass article or a consumer electronic product.

A glass composition includes: Si.sub.2O, greater than 15 mol % to less than or equal to 32 mol % Al.sub.2O.sub.3, B.sub.2O.sub.3, K.sub.2O, MgO, Na.sub.2O, and Li.sub.2O. The glass composition may have a fracture toughness of greater than or equal 0.75 MPa√m and a Young's modulus of greater than or equal to 80 GPa to less than or equal to 120 GPa. The glass composition is chemically strengthenable. The glass composition may be used in a glass article or a consumer electronic product.

A borophosphate glass composition including B.sub.2O.sub.3, P.sub.2O.sub.5, and CaO, and optionally a source additive selected from: Li.sub.2O, Na.sub.2O, K.sub.2O, Al.sub.2O.sub.3, ZnO, MgO, Fe.sub.2O.sub.3/FeO, CuO/Cu.sub.2O, and mixtures thereof, as defined herein. Also disclosed are bioactive compositions or substrates including the disclosed borophosphate glass composition, and at least one live cell. Also disclosed are methods of inhibiting or increasing the relative amount of species containing boron, phosphorous, or both, being released into an aqueous solution from aborophosphate glass composition defined herein. Also disclosed is a method of proliferating cells on a bioactive substrate as defined herein. Also disclosed are related glass compositions that exclude one of B.sub.2O.sub.3, P.sub.2O.sub.5, and CaO.

A borophosphate glass composition including B.sub.2O.sub.3, P.sub.2O.sub.5, and CaO, and optionally a source additive selected from: Li.sub.2O, Na.sub.2O, K.sub.2O, Al.sub.2O.sub.3, ZnO, MgO, Fe.sub.2O.sub.3/FeO, CuO/Cu.sub.2O, and mixtures thereof, as defined herein. Also disclosed are bioactive compositions or substrates including the disclosed borophosphate glass composition, and at least one live cell. Also disclosed are methods of inhibiting or increasing the relative amount of species containing boron, phosphorous, or both, being released into an aqueous solution from aborophosphate glass composition defined herein. Also disclosed is a method of proliferating cells on a bioactive substrate as defined herein. Also disclosed are related glass compositions that exclude one of B.sub.2O.sub.3, P.sub.2O.sub.5, and CaO.

An optical glass may be a phosphate based glass containing at least any one of oxides selected from TiO2, Nb2O5, WO3, and Bi2O2. The total content (HR) of the TiO2, Nb2O5, WO3, and Bi2O2 may be 35 mol % or above, the noble metal content may be less than 2.0 ppm, and the βOH value, given by the following general formula, may be 0.1 mm-1 or above: βOH=−[ln(B/A)]/t.

An optical glass may be a phosphate based glass containing at least any one of oxides selected from TiO2, Nb2O5, WO3, and Bi2O2. The total content (HR) of the TiO2, Nb2O5, WO3, and Bi2O2 may be 35 mol % or above, the noble metal content may be less than 2.0 ppm, and the βOH value, given by the following general formula, may be 0.1 mm-1 or above: βOH=−[ln(B/A)]/t.

Provided is a glass composition comprising a glass frit containing P.sub.2O.sub.5, SiO.sub.2, B.sub.2O.sub.3, Al.sub.2O.sub.3, ZrO.sub.2 and a group I-based oxide, wherein the P.sub.2O.sub.5 is contained in an amount of 10 to 30% by weight based on a total weight of the glass frit, wherein the SiO.sub.2 is contained in an amount of 20 to 40% by weight based on the total weight of the glass frit, wherein the B.sub.2O.sub.3 is contained in an amount of 5 wt % to 18 wt % based on the total weight of the glass frit, wherein the Al.sub.2O.sub.3 is contained in an amount of 15 to 30% by weight based on the total weight of the glass frit, wherein the ZrO.sub.2 is contained in an amount of 1 wt % to 8 wt % based on the total weight of the glass frit, wherein the Group I-based oxide is contained in an amount of 15 to 30% by weight based on the total weight of the glass frit.

An aluminoborate composition, an alumino-borosilicate glass composition, or a mixture thereof, and solid or hollow microspheres thereof, as defined herein. Also disclosed are methods of making and using the disclosed compositions, for example, forming microspheres for use in bioactive applications, and composition extracts for use in treating or healing wounds.

A coated glass or glass ceramic substrate includes a substrate with a surface area and a coating on that surface area. The coating includes a glass matrix and IR-reflecting pigments. The IR-reflecting pigments have a TSR value of at least 20%, as determined according to ASTM G 173. The coating, at a wavelength of 1500 nm, exhibits a remission of at least 35%, as measured according to ISO 13468.

Embodiments of glass ceramic articles and precursor glasses are disclosed. In one or more embodiments, the glass-ceramic articles are transparent and include a nepheline phase and a phosphate phase. The glass-ceramic articles are colorless and exhibit a transmittance of about 70% or greater across the visible spectrum. The glass-ceramic articles may optionally include a lithium aluminosilicate phase. The crystals of the glass-ceramic articles may have a major cross-section of about 100 nm or less.